A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Clinical trial NCT02019693 · COMPLETED
Trial details
- NCT number
- NCT02019693
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-24
- Primary completion
- 2021-12-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.